Serum Institute writes to PMO seeking reforms in drug regulations on non-COVID vaccines
Manufacture and stockpile of Covishield doses during the clinical trial helped bring the vaccine out quicker, protecting millions of lives, the letter said.
from http://www.firstpost.com/india/serum-institute-writes-to-pmo-seeking-reforms-in-drug-regulations-on-non-covid-vaccines-9380381.html
from http://www.firstpost.com/india/serum-institute-writes-to-pmo-seeking-reforms-in-drug-regulations-on-non-covid-vaccines-9380381.html
No comments: